KLN-205 Cells
USD$395.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | KLN-205 is a murine lung carcinoma cell line derived from an adult mouse. This cell line is widely used in cancer research, particularly for studying the mechanisms of lung cancer progression, metastasis, and potential therapeutic interventions. KLN-205 cells exhibit characteristics typical of non-small cell lung carcinoma (NSCLC), making them a valuable model for investigating the molecular and cellular underpinnings of this disease. Researchers utilize KLN-205 to evaluate the efficacy of various chemotherapeutic agents, immunotherapies, and targeted treatments, helping to advance the understanding of lung cancer biology and treatment strategies. KLN-205 cells are known for their robust growth and ability to form tumors when implanted in immunocompromised mice, providing a reliable in vivo model for preclinical studies. These cells are used to explore tumor-host interactions, immune responses to lung cancer, and the impact of genetic and epigenetic modifications on cancer development and progression. The KLN-205 cell line serves as a critical tool in oncology research, aiding in the identification of novel biomarkers and therapeutic targets for lung cancer. |
|---|---|
| Organism | Mouse |
| Tissue | Lung |
| Disease | Squamous cell carcinoma |
| Synonyms | KLN 205, KLN205 |
Characteristics
| Breed/Subspecies | DBA/2 |
|---|---|
| Growth properties | Adherent |
Regulatory Data
| Citation | KLN-205 (Cytion catalog number 400419) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 10090 |
| CellosaurusAccession | CVCL_3533 |
Biomolecular Data
| Tumorigenic | Yes, in DBA/2 and BDF1 mice |
|---|
Handling
| Culture Medium | EMEM (MEM Eagle), w: 2 mM L-Glutamine, w: 2.2 g/L NaHCO3, w: EBSS (Cytion article number 820100a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS and 1% NEAA |
| Dissociation Reagent | Accutase |
| Subculturing | Remove medium and rinse the adherent cells using PBS without calcium and magnesium (3-5 ml PBS for T25, 5-10ml for T75 cell culture flasks). Add TrypLE Express (1-2ml per T25, 2.5ml per T75 cell culture flask), the cell sheet must be covered completely. Incubate at 37 degree Celsius for 10 -15 minutes. Carefully resuspend the cells with medium (10 ml), centrifuge for 5 min at 300xg, resuspend cells in fresh medium and dispense into new flasks which contain fresh medium. |
| Fluid renewal | 2 to 3 times per week |
| Post-Thaw Recovery | After thawing, plate the cells at 5 x 104 cells/cm2 and allow the cells to recover from the freezing process and to adhere for at least 24 hours. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 400419-010925 | Certificate of Analysis | 22. Oct. 2025 | 400419 |